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Coagulation factor VII contains ten ~,.carbox),glutamic acid residues in the N-terminal region (Gla-domailO which are essential for the hemostatie 
function of FVII. The pre~ent study shows that granulocyte cathepsin G degrades the Gla-domain of FVlla in vitro. Characterization f the 
truncated FVIIa by SDS-PAGE and N-terminal amino acid sequence analysis revealed that cleavage had occurred between Tyr-44 and Ser-45 and 
that further cleavage was only obtained on e~tensive cathepsin G exposure. Cleavage of vitamin K-dependent coagulation factors by ¢athepsin 
G may play a role in vivo, and it offers a convenient way of obtaining proteitas deprived of their Gin-domain for functional and structural studies. 
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1. INTRODUCTION 
Biosynthesis of functional coagulation facto," VII re- 
quires a vitamin K-dependent post-translational y-car- 
boxylation of 10 glutamie acid residues in the N-termi- 
nal part of the molecule [1]. The Gla-domain is involved 
in a Ca"*-dependent binding of FVII to negatively 
charged phospholipids associated with cell surface- 
bound tissue factor [2]. Binding strongly promotes the 
conversion of the FVI1 zymogen to FVIIa, and also the 
enzymatic activity of FVIIa towards its substrates, FIX 
and FX, is profoundly enhanced [3,4]. 
Recent studies have shown that other vitamin K-de- 
pendent proteins, FX and protein C, were deprived of 
their Gin-domain upon exposure to cathepsin G [5,6]. 
This proteinase is one of several present in the azuro- 
philic granules of the polymorph nuclear granulocytes 
(neutrophils). When the neutrophils are activated by 
external stimuli, these active proteinases are secreted. 
Systemic activation and excessive release ofcathepsin G 
occurs in various diseased states, such as septicemia and 
leukaemia. The cathepsin G-mediated cleavage of the 
Gla-domains of coagulation factors may contribute to 
the deranged hemostatic balance observed in such con- 
ditions. We have investigated the effect on coagulation 
factor VIIa of exposure to cathepsin G under various 
conditions. 
Abbrevlationz: Gin, ?'-earboxyglutamic acid; GD-L, Gla-domainless 
light chain; L, light chain; H, heavy chain; IEF, isoeleetrie focusing: 
r, recombinant, RP, reverse phase; RI, retention time; TFPI, tissue 
factor pathway inhibitor; ATIII, antithrombin 111. 
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2. EXPERIMENTAL 
Recombinant FVIIa [7], 1 mg/ml was dialyzed against !0 mM Tris. 
HCI, pH 8,6 containing 75 mM NaCl and 5 mM CaCl:. Calcium ions 
were complc.xed with EDTA, added in an enters of 5 raM, before the 
incubation with cathepsin G at 370C. Cathepsin G, purified from 
human neutrophiles according to the method of Baugh and Travis [8], 
was a gift from Drs. H.J. Flodgaard and O. Nordfang (Novo Nordisk, 
Copenhagen). 
Specific clotting activity was determined in a one-.stage FVII clot- 
ting assay, using a FVII immunodeplcted human plasma s t~st ba~ 
and rabbit thromboplastin. 
lsoelectric focusing (IEF) was performed at 10°C, in ultrathin 1901- 
yacrylantide g ls (0.25 mm) fT=4%, C=5%) on a Multiphor II system 
(Pharmucia LKB, application ote 320). The rehydrated gels con- 
rained Pharmalyte 3-10 (4% w/v). The anode and cathode solutions 
were aspartic acid (40 raM) and NaOH (I M), respectively. 10/zg of 
protein were applied on a pre-focused gel (30 rain at 500 V) and 1,000 
V for 60 rain followed by 1,500 V for 75 rain were applied. The focused 
protein was precipitated for 20 rain with 20% TCA and stained for 20 
rain in 0.05% Coomassie R-250 in 25% isopropanol, 10% acetic acid. 
The dcstaining solution wa~ 40% methanol, 10% acetic acid. 
SDS-PAGE was p~ribrmed as de~erib~ in [9]. 10/ag of protein were 
applied on a linear gradient g~l, 10-15% w/v with 4.5% w/v .~taeking 
gel, A 45 mA constant current was applied for 3 h. The pl (17-04714)1) 
and molecular weight markers (17-0446-01)were purcha.~ed from 
Pharmacia.LKB. 
Reverse-phase high performance liquid chromatography (RP- 
HPLC), amino acid analysis and amino acid sequence analysis were 
performed as previously described [7,10]. 
3. RESULTS 
3. !. SDS-PAGE and clotting activity 
Fig. 1 shows the SDS-PAGE pattern during 120 rain 
incubation of recombinant (r) FVIIa with cathepsin G 
in the presence and absence of calcium ions. The con- 
trois (lanes 1-4) show the intact light (L) and heavy (H) 
chain. The preparation contained 5% H-chain degrada- 
tion products (molecular weight 15-17 kDa), generated 
Published by Elsevier Science Publishee.~' B.V. i 57 
Volume 306, number 2,3 FEBS LETTERS July 1992 
1 2 3 4 5 6 7 8 9 10 11 12 
~,~ . . . .  , . ~.:.~,-'~ . . : , , : , . "  ,.'~. :'.. ::...,..%.~. ' -~ . . . . .  • . : =...  ~¢ 
~i ~'~,~.' ~i~.,.'%~::~::, :~: ~i~.':~ ~ ~;~'":~i~ ~:'~:,I~ "" 
. ' .~ .~ , . , . . . , ,  . . . . . , c , . .~ : . .  . . : .~-  • . - . . . '~ ' . ' . ,~ . . , . . ' .  , . , .~" . "  . , .  ".-..,.... .~ ' . . . . . - . , .  
14 ~~:  :C~!~ :,.', .' :'-.-~~:.. ~,~- ~:". : ."~:~%. ";;.'::~.:. ~:~>"; .'~.- ":. ,.:~-";' .'..;" ~.:' .. . 
T~e(rnm) 20 120 20 120 20 120 5 I0 20 60 120 
CathepsinG 0 0 0 0 ÷ + ÷ ÷ ÷ + ÷ 
CaCl2 ÷ + 0 0 ÷ + 0 0 0 0 0 
Fig. I. SDS-PAGE of cathepsln G.de~aded rF3/Ila, rFVIIA (I m~ml) was incubated at37~C in the pre-~¢nce and absence ofcalcium ions (5 raM 
CaCI~.). with and without cathepsin O (1/500 w/w). At the indicated intervals, aliquots were ither diluted into 1% SDS, 1% DTT and boiled for 
SDS.PAGE or diluted in Ca:" containing buffer, on ice. for clottin~ analysis (Table 1). Molecular weight markers, lane 5. 
during the activation of the rFVII and co-purifying with 
the intact rFVlIa [7]. After 2 h exposure to cathepsin G
(1/500 w/w) in the presence of calcium ions, a slight 
degradation of the L-chain to a lower molecular weight 
form (lanes 6 and '7) was detectable. If calcium ions were 
omitted, the cleavage or the L-chain was completed 
within 5 min (lane 8). With a 10-fold increased ratio of 
cathepsin G to rFVIIa (1/50 w/w) an additional cleav- 
age of the H-chain could be demonstrated after 60 rain. 
This H-chain cleavage was completed within 120 rain 
(data not shown). The reduction in molecular weight 
corresponded to removal of the Gla-domain, and the 
FVII clotting activity was lost accordingly (Table I). 
3.2. RP-HPCL and N-tet'minal amino acid sequencing 
The products of cathepsin G-mediated cleavage or 
rFVlla were isolated by RP-HPCL (Fig. 2). Amino acid 
analysis of the minor peaks recovered prior to the 
cathepsin G peak (Rt 22 rain), indicated that the Gla- 
domain had been further degraded, and SDS-PAGE 
showed that the peaks, lo~.ated in between the cathepsin 
G peak and the main protein peak (Rt 27 rain) corre- 
sponded to H-chain degraded forms. 
N-Terminal amino acid sequencing of the protein 
from the main peak showed two N-terminal sequences~ 
one from the L-chain, starting at position Ser.45, 'and 
one from the H-chain, starting at Ile-153 (Table II), 
confirming that the Gin-domain was lost under the ap- 
plied conditions. 
3.3. lsoelectric focztsing 
The effect of the Gla-domain on the IEF pattern is 
shown in Fig. 3. Intact rFVlla is precipitated when 
applied at the anodic site (lane 2). Smearing, observed 
after application at the cathodic site (lane 5), indicates 
that steady-state conditions had probably not been ob- 
tained. In contrast the Gla-domainless rFVlla, applied 
Table I 
Perce,atage of FVII clotting activity after exposure to cathepsin G
Cathep- CaCl_~ 
sin G 
Incubation time (rain) 
5 10 20 60 120 
0 + ND ND 100% ND 97% 
0 0 NID ND 100% ND 95% 
+ + ND ND 72.% ND 77% 
+ 0 1.5% 0,6% 0% 0% 0% 
The data w~re obtained from the experiment described in Fig, I. 
Aliquots diluted in Ca2÷-coataining buffer were stored frozen until the 
time for analysis, FVII clotting activity i~; given as a percentage of the 
initial specific activity (26 U//.tg rFVlla). ND, not determined. 
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Fig. 2, RP-HPLC of eathepsin G-degraded rFVlla 0.5 mg of rFVlla, 
incubated for 20 min at 37°C with eathepsin G (1/50 w/w), were 
applied. Fractions absorbing at 214 nm were collected and concen- 







3 cm from either electrode, resulted in an identical IEF 
pattern, consisting of eight sharply focused bands, with 
pI values ranging from 5.8 to 7.8 (lanes 1 and 4). 
4, DISCUSSION 
Cathepsin G is a serine protease from human gran- 
ulocytes, involved in connective tissue degradation. The 
enzyme cleaves predominantly after Phe, Ala or Leu, 
with a substantial prel'erence for Phe over the other two 
aromatic amino acids, Tyr and Trp [11]. 
Cathepsin G cleaves human FX and protein C be- 
tween Phe-40 and Trp-41 [5,6]. This sequence is also 
present in FVII (Fig. 4). The FVIIa might be cleaved in 
this position too, however, under the conditions used, 
the main product contained only the Set-45 N-terminal 
from the FVII L-chain, favouring cleavage after Tyr-44. 
The homologous position in human protein C con- 
tains a His, in contrast o the other vitamin K-depend- 
ent coagulation enzymes (Fig. 4). Human FX has a 
lysine residue, adjacent o Tyr-44, which might lower 
the affinity for the cathepsin G [i i]. 
Other methods for producing Gla-domainless forms 
of FVIIa have been tried. In our hands chymotrypfin 
cleavage seems to introduce a more extended proteoly- 
sis (results not shown), as also observed uring thyme- 
trypsin cleavage of bovine FX [12]. The incubation of 
rFVIIa with EDTA for 48 h results in a Gla-domainless 
form which lacks the first 38 amino acids (des-l-38- 
rFVIIa) and without clotting activity [2]. Using a low 
enzyme to substrate ratio (1/500 w/w), the cathepsin G 
cleavage, reported here, gives a des-l-44-rFVlla within 
5 to I0 min, in the absence of calcium ions, with no 
significant H-chain cleavage during the 120 rain obser- 
vation period, H-chain cleavage requires a longer incu- 
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Fi~. 3. IEF of rFVlla and GD-rFVila. Intact rFVIla (lanes 2and 5) 
and cathepsin G-treated rFVIla (lanes 1 and 4) were applied anodie 
(lanes 1 and 2) and cathodic (lan~ 4 and 5). Marker proteins were 
applied in lan~ 3 and 6. 
Cathepsin G cleavage of FVIIa for preparing a Gla- 
domainless fcrm is found to be a convenient method. 
It might be utilized for obtaining consistent IEF pat- 
terns, as well as for other structural and functional stud- 
ies of coagulation factors. 
The cathepsin G cleavage of human FX and protein 
C [5,6] and the chymotrypsin cleavage of bovine FX [I 2] 
was found to be inhibited by calcium ions. 
Residues 1-48 of FVII are homologous with the com- 
parable N-terminal sequences of factors !I, IX and X 
and the proteins designated C, S and Z. Only one of 
these so called Gla-domains, present as part of the 
prothrombin fragment 1 of FII, has been crystallized 
and analysed by X-ray diffraction [13]. In the absence 
Table il 
Amino acid sequence analysis or cathgpsiq G-degraded RFVila 
Cycle no. Light chain (45-152) Heavy chain 
PTH.aa Yield (pmol) PTH-aa Yield (pmol) 
1 Ser 324 lie 835 
2 Asp 383 Val 904 
3 Gly* (633) Gly* (633} 
4 Asp 400 Gly 688 
5 Gin 563 Lys 682 
6 Cys*  N D Val 8 ! 8 
7 Ala 525 Cys** ND 
*In cycle no. 3 Ihe n~mc amino acid residue appears in both iil~hl 
(45-152) and heavy chain. In this ca~ tile amount isequally divided. 
**PTH-Cys is not determined. 
ND, not determined. 
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l'h~t¢in Residue no. RefercP.g~ 
35 3"/ 40 41 ,14 45 
I'Vll y R T K L F '~N ! S Y S n O I l l  
Prot¢inC D D T L A F W S K H V D G 1141 
I' 1~ T N 1' F W N K Y IK D G 115] 
FIX y K T T y F W K Q Y V D G llOl 
FI[ T A T D V F .W A g Y T A 11'71 
? : l'.¢arboxylated glutami¢ acid r~idu¢. 
Fig, 4, Homologous ,~¢qucne¢,~ of human vitamin K-dependent coagu- 
lation enzymes, 
of calcium ions the Gla-domain of prothrombin is 
highly disordered. Addition of calcium ions induces a 
folding of the polypeptide and these cations interact 
with the ~'-carboxy residues to provide a stable confor- 
mation of the domain [131. This picture of the Gla- 
domain is easily conipatible with the result obtained in 
this and previous studies. We suggest hat the removal 
of the calcium ions at the same time induces an unfold- 
ing of the Gla-domain, thereby increasing the accessibil- 
ity of proteolytic attack, and produces a high negative 
charge density, leading to an increased interaction be- 
tween the Gla-domain and an area of high positive 
charge density known to be present near the substrate 
binding site of eathepsin G. 
Degradation of vitamin K-dependent coagulation 
factors by granuloeyte proteinases reported in this and 
in other studies [6,12] indicate an inhibitory role for 
neutrophils on coagulation. On the other hand, leuko- 
cyte elastase-mediated degradation of coagulation in- 
hibitors, such as ATIII [18] and TFPI [19], as well as the 
cathepsin G-mediated degradation of protein C [5], are 
expected to have the opposite effect. Until the relative 
importance of the various leukocyte proteinase-medi. 
ated reactions have been quantified, it is not possible to 
evaluate the net result of neutrophil stimulation on 
blood coagulation. An important aspect in this context 
is the modulatory role of Ca-'* and glycosamino- 
glucans. 
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